Nanopore sequencing enables rapid diagnosis and drug resistance profiling in refractory <i>Mycoplasma pneumoniae</i> pneumonia: a case report. [PDF]
Liu Y, Xu L, Chang Y, Chen X.
europepmc +1 more source
Initial presentation, etiology and risk factors for adverse outcomes in infection-associated plastic bronchitis in children: a retrospective study. [PDF]
Cao H, Liang D, Huang H, He Q, Wu L.
europepmc +1 more source
Risk factors and clinical characteristics of fulminant Mycoplasma pneumoniae pneumonia in children: a retrospective case‒control study. [PDF]
Ren Y, Lin Y, Dai J.
europepmc +1 more source
Immune Dysregulation and Cytokine Profiling in Acute Mycoplasma pneumoniae Pneumonia. [PDF]
Wen Y +10 more
europepmc +1 more source
The expression and clinical value of <i>miR-222-3p</i> in children with <i>Mycoplasma</i> <i>pneumoniae</i> pneumonia. [PDF]
Huang Y +5 more
europepmc +1 more source
Independent risk factors and predictive model for high hospitalization costs in children with Mycoplasma pneumoniae pneumonia. [PDF]
Wang X +10 more
europepmc +1 more source
Quercetin-loaded silicon dioxide-graphene nanoparticles promotes M2 macrophage reprogramming in mycoplasma-induced pneumonia. [PDF]
Liu X +6 more
europepmc +1 more source
Nomogram to predict severe <i>Mycoplasma pneumoniae</i> pneumonia in children. [PDF]
Zhang Y, Min J, Gong L.
europepmc +1 more source
Comprehensive study of community acquired <i>Mycoplasma pneumoniae</i> pneumonia in children in Baoding, China, 2023. [PDF]
Bi J +8 more
europepmc +1 more source
Clinical efficacy comparison of Doxycycline versus Azithromycin combined with Methylprednisolone in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children. [PDF]
Zheng K, Zhou SH, Han ZB.
europepmc +1 more source

